H.C. Wainwright reiterates Arcadia Biosciences Inc. [RKDA] rating to buy and sets new price target at $8
H.C. Wainwright maintained its Arcadia Biosciences Inc. [RKDA] rating to the equivalent of a Buy but changed the price target to $8 from $10, in a research note dated Dec 28, 2020. That figure represents around a 67.75% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with H.C. […]
